Classification, Labelling and Packaging Regulation

No text on either side: this unit was named by a signal that carries no text, and only the structural diff carries any.

02008R1272-20160401 → 02008R1272-20170101

compared line by line: this provision is too large to compare word by word, so a marked line is a line that changed somewhere

ANNEX I CLASSIFICATION AND LABELLING REQUIREMENTS FOR HAZARDOUS SUBSTANCES AND MIXTURES This annex sets out the criteria for classification in hazard classes and in their differentiations and sets out additional provisions on how the criteria may be met. … 1,514 unchanged lines … This approach generally requires substantial supplemental technical information, and a highly trained and experienced expert (expert judgement, see section 1.1.1), to reliably estimate acute toxicity. If such information is not available, proceed to paragraph 3.1.3.6.2.3. 3.1.3.6.2.2. In the event that a component without any useable information for classification is used in a mixture at a concentration ≥ 1 %, it is concluded that the mixture cannot be attributed a definitive acute toxicity estimate. In this situation the mixture shall be classified based on the known components only, with the additional statement on the label and in the SDS that x per cent of the mixture consists of component(s) of unknown acute toxicity, taking into account the provisions set out in section 3.1.4.2. 3.1.3.6.2.3. If the total concentration of the relevant ingredient(s) with unknown acute toxicity is ≤ 10 % then the formula presented in section 3.1.3.6.1 shall be used. If the total concentration of the relevant ingredient(s) with unknown toxicity is > 10 %, the formula presented in section 3.1.3.6.1 shall be corrected to adjust for the percentage of the unknown ingredient(s) as follows: 100C unknown if10 %ATEmixnCiATEi 100Cunknown if10%ATEmixnCiATEi Table 3.1.2 Conversion from experimentally obtained acute toxicity range values (or acute toxicity hazard categories) to acute toxicity point estimates for use in the formulas for the classification of mixtures Exposure routes Classification Category or experimentally obtained acute toxicity range estimate Converted acute toxicity point estimate … 396 unchanged lines … 3.4.3.2. Classification of mixtures when data are not available for the complete mixture: bridging principles 3.4.3.2.1. Where the mixture itself has not been tested to determine its sensitising properties, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3. 3.4.3.3. Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture 3.4.3.3.1. The mixture shall be classified as a respiratory or skin sensitiser when at least one ingredient has been classified as a respiratory or skin sensitiser and is present at or above the appropriate generic concentration limit as shown in Table 3.4.5 for solid/liquid and gas respectively. 3.4.3.3.1. The mixture shall be classified as a respiratory or skin sensitiser when at least one ingredient has been classified as a respiratory or skin sensitiser and is present at or above the appropriate generic concentration limit as shown in Table 3.4.5 for solid/liquid and gas respectively. 3.4.3.3.2. Some substances that are classified as sensitisers may elicit a response, when present in a mixture in quantities below the concentrations established in Table 3.4.5, in individuals who are already sensitised to the substance or mixture (see Note 1 to Table 3.4.6). Table 3.4.5 Generic concentration limits of components of a mixture classified as either respiratory sensitisers or skin sensitisers that trigger classification of the mixture … 700 unchanged lines … Category Chronic 1: (Note 1) Chronic NOEC or ECx (for fish) ≤ 0,1 mg/l and/or Chronic NOEC or ECx (for crustacea) ≤ 0,1 mg/l and/or Chronic NOEC or ECx (for algae or other aquatic plants) ≤0,1 mg/l. Chronic NOEC or ECx (for algae or other aquatic plants) ≤ 0,1 mg/l. Category Chronic 2: Chronic NOEC or ECx (for fish) > 0,1 to ≤ 1 mg/l and/or Chronic NOEC or ECx (for crustacea) > 0,1 to ≤ 1 mg/l and/or … 230 unchanged lines … Symbol/pictogram Signal word Warning Hazard statement H420: Harms public health and the environment by destroying ozone in the upper atmosphere Precautionary statements P502

No text on either side: this unit was named by a signal that carries no text, and only the structural diff carries any.

02008R1272-20160401 → 02008R1272-20170101

compared line by line: this provision is too large to compare word by word, so a marked line is a line that changed somewhere

ANNEX III LIST OF HAZARD STATEMENTS, SUPPLEMENTAL HAZARD INFORMATION AND SUPPLEMENTAL LABEL ELEMENTS 1. Part 1: hazard statements … 580 unchanged lines … NL In grote hoeveelheden vatbaar voor zelfverhitting; kan vlam vatten. PL Substancja samonagrzewająca się w dużych ilościach; może się zapalić. PT Susceptível de auto-aquecimento em grandes quantidades: risco de inflamação. RO Se autoîncălzește, în cantități mari pericol de aprindere. RO Se autoîncălzește în cantități mari; pericol de aprindere. SK Vo veľkých množstvách sa samovoľne zahrieva; môže sa vznietiť. SL Samosegrevanje v velikih količinah; lahko povzroči požar. FI Suurina määrinä itsestään kuumeneva; voi syttyä palamaan. … 155 unchanged lines … SV Innehåller gas under tryck. Kan explodera vid uppvärmning. H281 Language 2.5 — Gases under pressure: Refrigerated liquefied gas BG Съдържа охладен газ; може да причини криогенни изгаряния или наранявания. ES Contiene un gas refrigerado; puede provocar quemaduras o lesiones criogénicas. ES Contiene gas refrigerado; puede provocar quemaduras o lesiones criogénicas. CS Obsahuje zchlazený plyn; může způsobit omrzliny nebo poškození chladem. DA Indeholder nedkølet gas, kan forårsage kuldeskader. DE Enthält tiefkaltes Gas; kann Kälteverbrennungen oder -Verletzungen verursachen. DE Enthält tiefgekühltes Gas; kann Kälteverbrennungen oder -verletzungen verursachen. ET Sisaldab külmutatud gaasi; võib põhjustada külmapõletusi või -kahjustusi. EL Περιέχει αέριο υπό ψύξη· μπορεί να προκαλέσει εγκαύματα ψύχους ή τραυματισμούς. EN Contains refrigerated gas; may cause cryogenic burns or injury. … 573 unchanged lines … DE Kann vermutlich Krebs erzeugen <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>. ET Arvatavasti põhjustab vähktõbe <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>. EL Ύποπτο για πρόκληση καρκίνου <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>. EN Suspected of causing cancer <state route of exposure if it is conclusively proven that no other routs of exposure cause the hazard>. EN Suspected of causing cancer <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>. FR Susceptible de provoquer le cancer <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>. GA Ceaptar go bhféadfadh sé a bheith ina chúis le hailse <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>. HR Sumnja na moguće uzrokovanje raka <navesti način izloženosti ako je nedvojbeno dokazano da niti jedan drugi način izloženosti ne uzrokuje takvu opasnost>. … 37 unchanged lines … SV Kan skada fertiliteten eller det ofödda barnet <ange specifik effekt om denna är känd> <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>. H361 Language 3.7 — Reproductive toxicity, Hazard Category 2 BG Предполага се, че уврежда оплодителната способност или плода < да се посочи конкретното въздействие, ако е известно > < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >. ES Se sospecha que perjudica la fertilidad o daña al feto <indíquese el efecto específico si se conoce> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>. ES Se sospecha que puede perjudicar la fertilidad o dañar el feto <indíquese el efecto específico si se conoce> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>. CS Podezření na poškození reprodukční schopnosti nebo plodu v těle matky <uveďte specifický účinek, je-li znám> <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>. DA Mistænkt for at skade forplantningsevnen eller det ufødte barn <angiv specifik effekt, hvis kendt> <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>. DE Kann vermutlich die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen < konkrete Wirkung angebe, n sofern bekannt > <Expositionsweg angeben, sofern schlüssig belegt ist, dass die Gefahr bei keinem anderen Expositionsweg besteht> DE Kann vermutlich die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen <konkrete Wirkung angeben, sofern bekannt> <Expositionsweg angeben, sofern schlüssig belegt ist, dass die Gefahr bei keinem anderen Expositionsweg besteht> ET Arvatavasti kahjustab viljakust või loodet <märkida spetsiifiline toime, kui see on teada> <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>. EL Ύποπτο για πρόκληση βλάβης στη γονιμότητα ή στο έμβρυο <αναφέρεται η ειδική επίπτωση εάν είναι γνωστή> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>. EN Suspected of damaging fertility or the unborn child <state specific effect if known> <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>. … 140 unchanged lines … SV Kan orsaka organskador <eller ange vilka organ som påverkas om detta är känt> genom lång eller upprepad exponering <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>. H300 + H310 Language 3.1 — Acutetoxicity (oral) and acute toxicity (dermal), hazard category 1, 2 H310 Language 3.1 — Acute toxicity (oral) and acute toxicity (dermal), hazard category 1, 2 BG Смъртоносен при поглъщане или при контакт с кожата ES Mortal en caso de ingestión o en contacto con la piel CS Při požití nebo při styku s kůží může způsobit smrt … 20 unchanged lines … SV Dödligt vid förtäring eller vid hudkontakt H300 + H330 Language 3.1 — Acutetoxicity (oral) and acute toxicity (inhalation), hazard category 1, 2 H330 Language 3.1 — Acute toxicity (oral) and acute toxicity (inhalation), hazard category 1, 2 BG Смъртоносен при поглъщане или при вдишване ES Mortal en caso de ingestión o inhalación CS Při požití nebo při vdechování může způsobit smrt … 20 unchanged lines … SV Dödligt vid förtäring eller inandning H310 + H330 Language 3.1 — Acutetoxicity (dermal) and acute toxicity (inhalation), hazard category 1, 2 H330 Language 3.1 — Acute toxicity (dermal) and acute toxicity (inhalation), hazard category 1, 2 BG Смъртоносен при контакт с кожата или при вдишване ES Mortal en contacto con la piel o si se inhala CS Při styku s kůží nebo při vdechování může způsobit smrt … 344 unchanged lines … CS Škodlivý pro vodní organismy, s dlouhodobými účinky. DA Skadelig for vandlevende organismer, med langvarige virkninger. DE Schädlich für Wasserorganismen, mit langfristiger Wirkung. ET Ohtlik veeorganismidele, pikaajaline toime. ET Kahjulik veeorganismidele, pikaajaline toime. EL Επιβλαβές για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις. EN Harmful to aquatic life with long lasting effects. FR Nocif pour les organismes aquatiques, entraîne des effets néfastes à long terme. … 69 unchanged lines … ES Explosivo en estado seco. CS Výbušný v suchém stavu. DA Eksplosiv i tør tilstand. DE In trockenem Zustand explosionsgefährlich. DE In trockenem Zustand explosiv. ET Plahvatusohtlik kuivana. EL Εκρηκτικό σε ξηρή κατάσταση. EN Explosive when dry. … 62 unchanged lines … FI Reagoi voimakkaasti veden kanssa. SV Reagerar häftigt med vatten. EUH 018 Language BG При употреба може да се образува запалима/експлозивна паровъздушнa смес. ES Al usarlo pueden formarse mezclas aire-vapor explosivas o inflamables. ES Al usarlo, pueden formarse mezclas aire-vapor explosivas o inflamables. CS Při používání může vytvářet hořlavé nebo výbušné směsi par se vzduchem. DA Ved brug kan brandbarlige dampe/eksplosive damp-luftblandinger dannes. DE Kann bei Verwendung explosionsfähige/entzündbare Dampf/Luft-Gemische bilden. … 254 unchanged lines … Achtung! Enthält Blei. 201 201A ET Sisaldab pliid. Mitte kasutada pindadel, mida lapsed võivad närida või imeda. Ettevaatust! Sisaldab pliid. Hoiatus! Sisaldab pliid. 201 201A EL Περιέχει μόλυβδο. Να μη χρησιμοποιείται σε επιφάνειες που είναι πιθανόν να μασήσουν ή να πιπιλίσουν τα παιδιά. Προσοχή! Περιέχει μόλυβδο. … 148 unchanged lines … CS Pozor! Nepoužívejte společně s jinými výrobky. Může uvolňovat nebezpečné plyny (chlor). DA Advarsel! Må ikke anvendes i forbindelse med andre produkter. Farlige luftarter (chlor) kan frigøres. DE Achtung! Nicht zusammen mit anderen Produkten verwenden, da gefährliche Gase (Chlor) freigesetzt werden können. ET Ettevaatust! Mitte kasutada koos teiste toodetega. Segust võib eralduda ohtlikke gaase (kloori). ET Hoiatus! Mitte kasutada koos teiste toodetega. Segust võib eralduda ohtlikke gaase (kloori). EL Προσοχή! Να μην χρησιμοποιείται σε συνδυασμό με άλλα προϊόντα. Μπορεί να ελευθερωθούν επικίνδυνα αέρια (χλώριο). EN Warning! Do not use together with other products. May release dangerous gases (chlorine). FR Attention! Ne pas utiliser en combinaison avec d'autres produits. Peut libérer des gaz dangereux (chlore). … 17 unchanged lines … CS Pozor! Obsahuje kadmium. Při používání vznikají nebezpečné výpary. Viz informace dodané výrobcem. Dodržujte bezpečnostní pokyny. DA Advarsel! Indeholder cadmium. Der udvikles farlige dampe under anvendelsen. Se producentens oplysninger. Overhold sikkerhedsforskrifterne. DE Achtung! Enthält Cadmium. Bei der Verwendung entstehen gefährliche Dämpfe. Hinweise des Herstellers beachten. Sicherheitsanweisungen einhalten. ET Ettevaatust! Sisaldab kaadmiumi. Kasutamisel moodustuvad ohtlikud aurud. Vt tootja esitatud teavet. Järgida ohutuseeskirju. ET Hoiatus! Sisaldab kaadmiumi. Kasutamisel moodustuvad ohtlikud aurud. Vt tootja esitatud teavet. Järgida ohutuseeskirju. EL Προσοχή! Περιέχει κάδμιο. Κατά τη χρήση αναπτύσσονται επικίνδυνες αναθυμιάσεις. Βλέπετε πληροφορίες του κατασκευαστή. Τηρείτε τις οδηγίες ασφαλείας. EN Warning! Contains cadmium. Dangerous fumes are formed during use. See information supplied by the manufacturer. Comply with the safety instructions. FR Attention! Contient du cadmium. Des fumées dangereuses se développent pendant l'utilisation. Voir les informations fournies par le fabricant. Respectez les consignes de sécurité. … 155 unchanged lines … SL Da bi se izognili tveganjem za ljudi in okolje, ravnajte v skladu z navodili za uporabo. FI Noudata käyttöohjeita ihmisen terveydelle ja ympäristölle aiheutuvien vaarojen välttämiseksi. SV För att undvika risker för människors hälsa och för miljön, följ bruksanvisningen.

02008R1272-20160401 → 02008R1272-20170101

compared line by line: this provision is too large to compare word by word, so a marked line is a line that changed somewhere

ANNEX IV LIST OF PRECAUTIONARY STATEMENTS In selecting the precautionary statements in accordance with Articles 22 and 28(3), suppliers may combine the Precautionary Statements in the table below, having regard to clarity and comprehensibility of the precautionary advice. … 414 unchanged lines … Table 1.2 Precautionary statements — Prevention P201 Language BG Преди употреба се снабдете със специални инструкции. ES Pedir instrucciones especiales antes del uso. ES Solicitar instrucciones especiales antes del uso. CS Před použitím si obstarejte speciální instrukce. DA Indhent særlige anvisninger før brug. DE Vor Gebrauch besondere Anweisungen einholen. ET Enne kasutamist tutvuda erijuhistega. EL Εφοδιαστείτε με τις ειδικές οδηγίες πριν από τη χρήση. EN Obtain special instructions before use. FR Se procurer les instructions avant utilisation. FR Se procurer les instructions spéciales avant utilisation. GA Faigh treoracha speisialta roimh úsáid. HR Prije uporabe pribaviti posebne upute. IT Procurarsi istruzioni specifiche prima dell’uso. … 128 unchanged lines … SK Prijmite opatrenia na zabránenie zmiešania s horľavými materiálmi… SL Preprečiti mešanje z vnetljivimi snovmi … FI Varo sekoittamasta syttyvien materiaalien… kanssa. SV Undvik att blanda med med brännbara ämnen… SV Undvik att blanda med brännbara ämnen… P222 Language BG Не допускайте конктакт с въздух. ES No dejar que entre en contacto con el aire. CS Zabraňte styku se vzduchem. DA Undgå kontakt med luft. DE Kontakt mit Luft nicht zulassen. DE Keinen Kontakt mit Luft zulassen. ET Hoida õhuga kokkupuute eest. EL Να μην έρθει σε επαφή με τον αέρα. EN Do not allow contact with air. … 209 unchanged lines … ES Utilizar un material eléctrico, de ventilación o de iluminación/…/antideflagrante. CS Používejte elektrické/ventilační/osvětlovací/…/zařízení do výbušného prostředí. DA Anvend eksplosionssikkert elektrisk/ventilations-/lys-/…/udstyr. DE Explosionsgeschützte elektrische Betriebsmittel/Lüftungsanlagen/Beleuchtung/… verwenden. DE Explosionsgeschützte elektrische Geräte/Lüftungsanlagen/Beleuchtungsanlagen/… verwenden. ET Kasutada plahvatuskindlaid elektri-/ventilatsiooni-/valgustus-/…/seadmeid. EL Να χρησιμοποιείται αντιεκρηκτικός ηλεκτρολογικός/εξαερισμού/φωτιστικός/…/εξοπλισμός. EN Use explosion-proof electrical/ventilating/lighting/…/equipment. … 41 unchanged lines … ES Tomar medidas de precaución contra descargas electrostáticas. CS Proveďte preventivní opatření proti výbojům statické elektřiny. DA Træf foranstaltninger mod statisk elektricitet. DE Maßnahmen gegen elektrostatische Aufladungen treffen. DE Maßnahmen gegen elektrostatische Entladungen treffen. ET Rakendada ettevaatusabinõusid staatilise elektri vastu. EL Λάβετε προστατευτικά μέτρα έναντι ηλεκτροστατικών εκκενώσεων. EN Take precautionary measures against static discharge. … 211 unchanged lines … DA Der må ikke spises, drikkes eller ryges under brugen af dette produkt. DE Bei Gebrauch nicht essen, trinken oder rauchen. ET Toote käitlemise ajal mitte süüa, juua ega suitsetada. EL Μην τρώτε, πίνετεή καπνίζετε, όταν χρησιμοποιείτε αυτό το προϊόν. EN Do no eat, drink or smoke when using this product. EL Μην τρώτε, πίνετε ή καπνίζετε, όταν χρησιμοποιείτε αυτό το προϊόν. EN Do not eat, drink or smoke when using this product. FR Ne pas manger, boire ou fumer en manipulant ce produit. GA Ná hith, ná hól agus ná caitear tobac agus an táirge seo á úsáid. HR Pri rukovanju proizvodom ne jesti, piti niti pušiti. … 134 unchanged lines … ES Llevar guantes que aíslen del frío/gafas/máscara. CS Používejte ochranné rukavice proti chladu/obličejový štít/ochranné brýle. DA Bær kuldeisolerende handsker/ansigtsskærm/øjenbeskyttelse. DE Schutzhandschuhe/Gesichtsschild/Augenschutz mit Kälteisolierung tragen. DE Schutzhandschuhe mit Kälteisolierung/Gesichtsschild/Augenschutz tragen. ET Kanda külmakaitsekindaid/kaitsemaski/kaitseprille. EL Φοράτε μονωτικά γάντια προστασίας από το ψύχος/προστατευτική μάσκα/προστατευτικά γυαλιά. EN Wear cold insulating gloves/face shield/eye protection. FR Porter des gants isolants contre le froid/un équipement de protection du visage/des yeux. GA Caith lámhainní inslithe fuachta/aghaidhsciath/cosaint súile. HR Nositi zaštitne rukavice za hladnoću/zaštitu za lice/zaštitu za oči. IT Utilizzare guanti termici/schermo facciale/Proteggere gli occhi. LV Izmantot aizsargcimdus/sejas aizsargus/acu aizsargus ar aukstuma izolāciju. LT Mūvėti nuo šalčio izoliuojančias pirštines/naudoti veido skydelį/akių apsaugos priemones. HU Hidegszigetelő kesztyű/arcvédő/szemvédő használata kötelező. MT Ilbies ingwanti kiesħa li ma jinfedx minnhom/ilqugħ għall-wiċċ/protezzjoni għall-għajnejn. NL Koude-isolerende handschoenen/gelaatsbescherming/oogbescherming dragen. NL Gelaatsbescherming/oogbescherming/koude-isolerende handschoenen dragen. PL Nosić rękawice izolujące od zimna/maski na twarz/ochronę oczu. PT Usar luvas de protecção contra o frio/escudo facial/protecção ocular. RO Purtați mănuși izolante împotriva frigului/echipament de protecție a feței/ochilor. … 247 unchanged lines … ES EN CASO DE CONTACTO CON LA ROPA: CS PŘI STYKU S ODĚVEM: DA VED KONTAKT MED TØJET: DE BEI KONTAMINIERTER KLEIDUNG: DE BEI KONTAKT MIT DER KLEIDUNG: ET RÕIVASTELE SATTUMISE KORRAL: EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΡΟΥΧΑ: EN IF ON CLOTHING: … 378 unchanged lines … CS Při podráždění kůže nebo vyrážce: DA Ved hudirritation eller udslet: DE Bei Hautreizung oder -ausschlag: ET Nahaärrituse või _obe korral: ET Nahaärrituse või lööbe korral: EL Εάν παρατηρηθεί ερεθισμός του δέρματος ή εμφανιστεί εξάνθημα: EN If skin irritation or rash occurs: FR En cas d’irritation ou d’éruption cutanée: … 193 unchanged lines … HR Pri otežanom disanju: IT In caso di sintomi respiratori: LV Ja rodas elpošanas traucējumu simptomi: LT Jeigu pasireiškia respiraciniai simptomai: LT Jeigu pasireiškia kvėpavimo sutrikimo simptomai: HU Légzési problémák esetén: MT Jekk tkun qed tbati minn sintomi respiratorji: NL Bij ademhalingssymptomen: … 627 unchanged lines … ES EN CASO DE CONTACTO CON LA PIEL: Sumergir en agua fresca/aplicar compresas húmedas. CS PŘI STYKU S KŮŽÍ: Ponořte do studené vody/zabalte do vlhkého obvazu. DA VED KONTAKT MED HUDEN: Skyl under koldt vand/anvend våde omslag. DE BEI KONTAKT MIT DER HAUT: In kaltes Wasser tauchen/nassen Verband anlegen. DE BEI BERÜHRUNG MIT DER HAUT: In kaltes Wasser tauchen/nassen Verband anlegen. ET NAHALE SATTUMISE KORRAL: hoida jahedas vees/panna peale niiske kompress. EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύντε με άφθονο δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους. EN IF ON SKIN: Immerse in cool water/wrap in wet bandages. … 137 unchanged lines … ES EN CASO DE CONTACTO CON LOS OJOS: Aclarar cuidadosamente con agua durante varios minutos. Quitar las lentes de contacto, si lleva y resulta fácil. Seguir aclarando. CS PŘI ZASAŽENÍ OČÍ: Několik minut opatrně vyplachujte vodou. Vyjměte kontaktní čočky, jsou-li nasazeny a pokud je lze vyjmout snadno. Pokračujte ve vyplachování. DA VED KONTAKT MED ØJNENE: Skyl forsigtigt med vand i flere minutter. Fjern eventuelle kontaktlinser, hvis dette kan gøres let. Fortsæt skylning. DE BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen. DE BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen. ET SILMA SATTUMISE KORRAL: loputada mitme minuti jooksul ettevaatlikult veega. Eemaldada kontaktläätsed, kui neid kasutatakse ja kui neid on kerge eemaldada. Loputada veel kord. EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΜΑΤΙΑ: Ξεπλύνετε προσεκτικά με νερό για αρκετά λεπτά. Εάν υπάρχουν φακοί επαφής, αφαιρέστε τους, εφόσον είναι εύκολο. Συνεχίστε να ξεπλένετε. EN IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. FR EN CAS DE CONTACT AVEC LES YEUX: rincer avec précaution à l’eau pendant plusieurs minutes. Enlever les lentilles de contact si la victime en porte et si elles peuvent être facilement enlevées. Continuer à rincer. GA I gCÁS TEAGMHÁLA LEIS NA SÚILE: Sruthlaigh go cúramach le huisce ar feadh roinnt nóiméad. Tóg amach na tadhall-lionsaí, más ann dóibh agus más furasta. Lean den sruthlú. HR U SLUČAJU DODIRA S OČIMA: oprezno ispirati vodom nekoliko minuta. Ukloniti kontaktne leće ukoliko ih nosite i ako se one lako uklanjaju. Nastaviti ispiranje. IT IN CASO DI CONTATTO CON GLI OCCHI: sciacquare accuratamente per parecchi minuti. Togliere le eventuali lenti a contatto se è agevole farlo. Continuare a sciacquare. LV SASKARĒ AR ACĪM: uzmanīgi izskalot ar ūdeni vairākas minūtes. Izņemt kontaktlēcas, ja tās ir ievietotas un ja to ir viegli izdarīt. Turpināt skalot. LT PATEKUS Į AKIS: Kelias minutes atsargiai plauti vandeniu. Išimti kontaktinius lęšius, jeigu jie yra ir jeigu lengvai galima tai padaryti. Toliau plauti akis. HU SZEMBE KERÜLÉS esetén: Több percig tartó óvatos öblítés vízzel. Adott esetben a kontaktlencsék eltávolítása, ha könnyen megoldható. Az öblítés folytatása. MT JEKK JIDĦOL FL-GĦAJNEJN: Laħlaħ b'attenzjoni bl-ilma għal diversi minuti. Neħħi l-lentijiet tal-kuntatt, jekk ikun hemm u jkunu faċli biex tneħħihom. Kompli laħlaħ. NL BIJ CONTACT MET DE OGEN: voorzichtig afspoelen met water gedurende een aantal minuten; contactlenzen verwijderen, indien mogelijk; blijven spoelen. PL W PRZYPADKU DOSTANIA SIĘ DO OCZU: Ostrożnie płukać wodą przez kilka minut. Wyjąć soczewki kontaktowe, jeżeli są i można je łatwo usunąć. Nadal płukać. PT SE ENTRAR EM CONTACTO COM OS OLHOS: enxaguar cuidadosamente com água durante vários minutos. Se usar lentes de contacto, retire-as, se tal lhe for possível. Continuar a enxaguar. RO ÎN CAZ DE CONTACT CU OCHII: clătiți cu atenție cu apă timp de mai multe minute. Scoateți lentilele de contact, dacă este cazul și dacă acest lucru se poate face cu ușurință. Continuați să clătiți. SK PO ZASIAHNUTÍ OČÍ: Niekoľko minút ich opatrne vyplachujte vodou. Ak používate kontaktné šošovky a ak je to možné, odstráňte ich. Pokračujte vo vyplachovaní. SL PRI STIKU Z OČMI: previdno izpirajte z vodo nekaj minut. Odstranite kontaktne leče, če jih imate in če to lahko storite brez težav. Nadaljujte z izpiranjem. FI JOS KEMIKAALIA JOUTUU SILMIIN: Huuhdo huolellisesti vedellä usean minuutin ajan. Poista piilolinssit, _edical voi tehdä helposti. Jatka huuhtomista. FI JOS KEMIKAALIA JOUTUU SILMIIN: Huuhdo huolellisesti vedellä usean minuutin ajan. Poista mahdolliset piilolinssit, jos sen voi tehdä helposti. Jatka huuhtomista. SV VID KONTAKT MED ÖGONEN: Skölj försiktigt med vatten i flera minuter. Ta ur eventuella kontaktlinser om det går lätt. Fortsätt att skölja. P306 + P360 Language BG ПРИ ПОПАДАНЕ ВЪРХУ ОБЛЕКЛОТО: незабавно облейте замърсеното облекло и кожата обилно с вода, преди да свалите дрехите. ES EN CASO DE CONTACTO CON LA ROPA: Aclarar inmediatamente con agua abundante las prendas y la piel contaminadas antes de quitarse la ropa. … 505 unchanged lines … ES Almacenar en un recipiente resistente a la corrosión/… con revestimiento interior resistente. CS Skladujte v obalu odolném proti korozi/… obalu s odolnou vnitřní vrstvou. DA Opbevares i ætsningsbestandig/…beholder med modstandsdygtig indvendig belægning. DE In korrosionsbeständigem/… Behälter mit korrosionsbeständiger Auskleidung aufbewahren. DE In korrosionsbeständigem/… Behälter mit widerstandsfähiger Innenauskleidung aufbewahren. ET Hoida sööbekindlas/…sööbekindla sisevooderdisega mahutis. EL Αποθηκεύεται σε ανθεκτικό στη διάβρωση/… περιέκτη με ανθεκτική εσωτερική επένδυση. EN Store in corrosive resistant/… container with a resistant inner liner. … 65 unchanged lines … ES Almacenar a temperaturas no superiores a … oC/…oF. CS Skladujte při teplotě nepřesahující … oC/…oF. DA Opbevares ved en temperatur, som ikke overstiger … oC/…oF. DE Bei Temperaturen von nicht mehr als … oC/…aufbewahren. DE Bei Temperaturen nicht über … oC/… oF aufbewahren. ET Hoida temperatuuril mitte üle … oC/… oF. EL Αποθηκεύεται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF. EN Store at temperatures not exceeding … oC/…oF. … 17 unchanged lines … ES No exponer a temperaturas superiores a 50 oC/122oF. CS Nevystavujte teplotě přesahující 50 oC/122 oF. DA Må ikke udsættes for en temperatur, som overstiger 50 oC/122oF. DE Nicht Temperaturen von mehr als 50 oC aussetzen. DE Nicht Temperaturen über 50 oC/122 oF aussetzen. ET Mitte hoida temperatuuril üle 50 oC/122 oF. EL Να μην εκτίθεται σε θερμοκρασίες που υπερβαίνουν τους 50 oC/122oF. EN Do not expose to temperatures exceeding 50 oC/122oF. … 17 unchanged lines … ES Almacenar las cantidades a granel superiores a … kg/… lbs a temperaturas no superiores a … oC/…oF. CS Množství větší než … kg/… liber skladujte při teplotě nepřesahující … oC/…oF. DA Bulkmængder på over … kg/…lbs opbevares ved en temperatur, som ikke overstiger … oC/…oF. DE Schüttgut in Mengen von mehr als … kg bei Temperaturen von nicht mehr als … oC aufbewahren DE Schüttgut in Mengen von mehr als … kg/… lbs bei Temperaturen nicht über … oC/… oF aufbewahren. ET Kogust, mis on suurem kui … kg/… naela, hoida temperatuuril mitte üle … oC/… oF. EL Οι σωροί χύδην με βάρος άνω των … kg/… lbs αποθηκεύονται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF. EN Store bulk masses greater than … kg/… lbs at temperatures not exceeding … oC/…oF. … 65 unchanged lines … ES Almacenar en un lugar seco. Almacenar en un recipiente cerrado. CS Skladujte na suchém místě. Skladujte v uzavřeném obalu. DA Opbevares et tørt sted. Opbevares i en lukket beholder. DE In einem geschlossenen Behälter an einem trockenen Ort aufbewahren. DE An einem trockenen Ort aufbewahren. In einem geschlossenen Behälter aufbewahren. ET Hoida kuivas. Hoida suletud mahutis. EL Αποθηκεύεται σε στεγνό μέρος. Φυλάσσεται σε κλειστό περιέκτη. EN Store in a dry place. Store in a closed container. … 17 unchanged lines … ES Almacenar en un lugar bien ventilado. Mantener el recipiente cerrado herméticamente. CS Skladujte na dobře větraném místě. Uchovávejte obal těsně uzavřený. DA Opbevares på et godt ventileret sted. Hold beholderen tæt lukket. DE Behälter dicht verschlossen an einem gut belüfteten Ort aufbewahren. DE An einem gut belüfteten Ort aufbewahren. Behälter dicht verschlossen halten. ET Hoida hästi ventileeritavas kohas. Hoida mahuti tihedalt suletuna. EL Αποθηκεύεται σε καλά αεριζόμενο χώρο. Ο περιέκτης διατηρείται ερμητικά κλειστός. EN Store in a well-ventilated place. Keep container tightly closed. … 17 unchanged lines … ES Almacenar en un lugar bien ventilado. Mantener en lugar fresco. CS Skladujte na dobře větraném místě. Uchovávejte v chladu. DA Opbevares på et godt ventileret sted. Opbevares køligt. DE Kühl an einem gut belüfteten Ort aufgewahren. DE An einem gut belüfteten Ort aufbewahren. Kühl halten. ET Hoida hästi ventileeritavas kohas. Hoida jahedas. EL Αποθηκεύεται σε καλά αεριζόμενο χώρο. Διατηρείται δροσερό. EN Store in a well-ventilated place. Keep cool. … 17 unchanged lines … ES Proteger de la luz del sol. Almacenar en un lugar bien ventilado. CS Chraňte před slunečním zářením. Skladujte na dobře větraném místě. DA Beskyttes mod sollys. Opbevares på et godt ventileret sted. DE Vor Sonnenbestrahlung geschützt an einem gut belüfteten Ort aufbewahren. DE Vor Sonnenbestrahlung schützen. An einem gut belüfteten Ort aufbewahren. ET Hoida päikesevalguse eest. Hoida hästi ventileeritavas kohas. EL Να προστατεύεται από τις ηλιακές ακτίνες. Αποθηκεύεται σε καλά αεριζόμενο χώρο. EN Protect from sunlight. Store in a well-ventilated place. … 17 unchanged lines … ES Proteger de la luz del sol. No exponer a temperaturas superiores a 50 oC/122oF. CS Chraňte před slunečním zářením. Nevystavujte teplotě přesahující 50 oC/122oF. DA Beskyttes mod sollys. Må ikke udsættes for en temperatur, som overstiger 50 oC/122oF. DE Vor Sonnenbestrahlung schützen und nicht Temperaturen von mehr als 50 oC aussetzen. DE Vor Sonnenbestrahlung schützen und nicht Temperaturen über 50 oC/122 oF aussetzen. ET Hoida päikesevalguse eest. Mitte hoida temperatuuril üle 50 oC/122 oF. EL Να προστατεύεται από τις ηλιακές ακτίνες. Να μην εκτίθεται σε θερμοκρασίες που υπερβαίνουν τους 50 oC/122oF. EN Protect from sunlight. Do no expose to temperatures exceeding 50 oC/122oF. … 17 unchanged lines … ES Almacenar a temperaturas no superiores a … oC/…oF. Mantener en lugar fresco. CS Skladujte při teplotě nepřesahující … oC/…oF. Uchovávejte v chladu. DA Opbevares ved en temperatur, som ikke overstiger … oC/…oF. Opbevares køligt. DE Kühl und bei Temperaturen von nicht mehr als … oC aufbewahren. DE Bei Temperaturen nicht über … oC/… oF aufbewahren. Kühl halten. ET Hoida temperatuuril mitte üle … oC/… oF. Hoida jahedas. EL Αποθηκεύεται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF. Διατηρείται δροσερό. EN Store at temperatures not exceeding … oC/…oF. Keep cool. … 63 unchanged lines … SL Za podatke glede obnovitve/reciklaže se obrnite na proizvajalca/dobavitelja FI Hanki valmistajalta/toimittajalta tietoja uudelleenkäytöstä/kierrätyksestä SV Rådfråga tillverkare/leverantör om återvinning/återanvändning

No text on either side: this unit was named by a signal that carries no text, and only the structural diff carries any.

02008R1272-20160401 → 02008R1272-20170101

compared line by line: this provision is too large to compare word by word, so a marked line is a line that changed somewhere

ANNEX VI Harmonised classification and labelling for certain hazardous substances Part 1 of this Annex provides an introduction to the list of harmonised classification and labelling, including information listed for each entry and related classifications and hazard statements in Table 3.1, subject to certain considerations arising from translating the classifications listed in Annex I to Directive 67/548/EEC. … 1,787 unchanged lines … Acute Tox. 4 * H312 H302 GHS07 Wng H312 H302 007-004-00-1 nitric acid … % 231-714-2 7697-37-2 Ox. Liq. 3 H302 007-004-00-1 nitric acid … % 231-714-2 7697-37-2 Ox. Liq. 2 Skin Corr. 1A H272 H314 GHS03 GHS05 Dgr H272 H314 Skin Corr. 1A; H314: C ≥ 20 % H314 EUH071 Skin Corr. 1A; H314: C ≥ 20 % Skin Corr. 1B; H314: 5 % ≤ C < 20 % Ox. Liq. 3; H272: C ≥ 65 % B Ox. Liq. 2; H272: C ≥ 99 % Ox. Liq. 3; H272: 99 % > C ≥ 65 % B 007-006-00-2 ethyl nitrite 203-722-6 109-95-5 Flam. Gas 1 Press. Gas Acute Tox. 4 * … 906 unchanged lines … Aquatic Chronic 3 H228 H412 GHS02 Dgr H228 H412 015-003-00-2 calcium phosphide; tricalcium diphosphide 215-142-0 1305-99-3 Water-react. 1 Acute Tox. 2 * H412 015-003-00-2 calcium phosphide; tricalcium diphosphide 215-142-0 1305-99-3 Water-react. 1 Acute Tox. 2 Acute Tox. 3 Acute Tox. 1 Eye Dam. 1 Aquatic Acute 1 H260 H300 H311 H330 H318 H400 GHS02 GHS06 GHS05 GHS09 Dgr H260 H300 H400 EUH029 M=100 015-004-00-8 aluminium phosphide 244-088-0 20859-73-8 Water-react. 1 H260 GHS02 H260 EUH029 M = 100 Acute Tox. 2 H300 GHS06 H300 EUH032 Acute Tox. 3 H311 GHS09 H311 Acute Tox. 1 H330 Dgr H330 Aquatic Acute 1 H400 H400 015-005-00-3 magnesium phosphide; H311 H330 H318 H400 EUH029 EUH032 M = 100 015-004-00-8 aluminium phosphide 244-088-0 20859-73-8 Water-react. 1 H260 GHS02 H260 EUH029 M = 100 Acute Tox. 2 H300 GHS06 H300 EUH032 Acute Tox. 3 H311 GHS09 H311 Acute Tox. 1 H330 Dgr H330 Aquatic Acute 1 H400 H400 015-005-00-3 magnesium phosphide; trimagnesium diphosphide 235-023-7 12057-74-8 Water-react. 1 H260 GHS02 H260 EUH029 M = 100 Acute Tox. 2 H300 GHS06 H300 EUH032 Acute Tox. 3 H311 GHS09 H311 Acute Tox. 1 H330 Dgr H330 Aquatic Acute 1 H400 H400 015-006-00-9 trizinc diphosphide; zinc phosphide 215-244-5 1314-84-7 Water-react. 1 Acute Tox. 2 * … 2,655 unchanged lines … H314 Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314: 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5 % ≤ C < 2 % Eye Irrit. 2; H319: 0,5 % ≤ C < 2 % 020-001-00-X calcium 231-179-5 7440-70-2 Water-react. 2 H261 GHS02 Eye Irrit. 2; H319: 0,5 % ≤ C < 2 % 019-003-00-3 potassium (E,E)-hexa-2,4-dienoate 246-376-1 24634-61-5 Eye Irrit. 2 H319 GSH07 Wng H319 020-001-00-X calcium 231-179-5 7440-70-2 Water-react. 2 H261 GHS02 Dgr H261 020-002-00-5 calcium cyanide 209-740-0 592-01-8 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 H300 … 2,290 unchanged lines … Wng H410 030-012-00-1 aluminium-magnesium-zinc-carbonate-hydroxide 423-570-6 169314-88-9 Aquatic Chronic 4 H413 H413 030-013-00-7 zinc oxide 215-222-5 1314-13-2 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 030-015-00-8 tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate 440-060-9 — Aquatic Chronic 2 H411 GHS09 H411 031-001-00-4 gallium arsenide 215-114-8 1303-00-0 Carc. 1B H350 GHS08 H350 STOT RE 1 H372 (respiratory and haematopoietic systems) Dgr H372 (respiratory and haematopoietic systems) 033-001-00-X arsenic 231-148-6 7440-38-2 Acute Tox. 3 * Wng H410 030-015-00-8 tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate 440-060-9 — Aquatic Chronic 2 H411 GHS09 H411 031-001-00-4 gallium arsenide 215-114-8 1303-00-0 Repr. 1B Carc. 1B STOT RE 1 H360F H350 H372 (respiratory and haematopoietic systems) GHS08 Dgr H360F H350 H372 (respiratory and haematopoietic systems) 033-001-00-X arsenic 231-148-6 7440-38-2 Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 H331 … 621 unchanged lines … H311 H301 H410 * A1 050-008-00-3 tributyltin compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 * Acute Tox. 4 * 050-008-00-3 tributyltin compounds, with the exception of those specified elsewhere in this annex — — Repr. 1B Acute Tox. 3 Acute Tox. 4* STOT RE 1 Skin Irrit. 2 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H301 Aquatic Chronic 1 H360FD H301 H312 H372** H315 H319 H315 H400 H410 GHS06 GHS08 H410 GHS08 GHS06 GHS09 Dgr H301 Dgr H360FD H301 H312 H372** H315 H319 H315 H410 * STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,25 % ≤ C < 1 % Skin Irrit. 2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % Skin Irrit. 2; H315:C ≥ 1 % Eye Irrit. 2; H319:C ≥ 1 % M = 10 A 1 050-009-00-9 fluorotripentylstannane; [1] … 4,416 unchanged lines … Dgr H225 EUH019 603-101-00-3 tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans) 405-040-6 — Eye Irrit. 2 H319 GHS07 Wng H319 603-102-00-9 1,2-epoxybutane 203-438-2 106-88-7 Flam. Liq. 2 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* STOT SE 3 Skin Irrit. 2 Aquatic Chronic 3 H225 Eye Irrit. 2 H225 H351 H302 H312 H332 H312 H302 H319 H335 H315 H412 GHS02 H319 GHS02 GHS08 GHS07 Dgr H225 H351 H302 H312 H332 H312 H302 H319 H335 H315 H412 603-103-00-4 oxirane, mono[(C12-14-alkyloxy)methyl] derivs. 271-846-8 68609-97-2 Skin Irrit. 2 H319 603-103-00-4 oxirane, mono[(C12-14-alkyloxy)methyl] derivs. 271-846-8 68609-97-2 Skin Irrit. 2 Skin Sens. 1 H315 H317 GHS07 Wng H315 … 590 unchanged lines … GHS09 Wng H302 H373 ** H411 603-197-00-7 tebuconazole (ISO); 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol 403-640-2 107534-96-3 Repr. 2 Acute Tox. 4 * Aquatic Chronic 2 H361d *** H411 603-197-00-7 tebuconazole (ISO); 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol 403-640-2 107534-96-3 Repr. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H361d*** H302 H411 GHS08 H400 H410 GHS08 GHS07 GHS09 Wng H361d *** Wng H361d*** H302 H411 603-199-00-8 etoxazol (ISO); H410 M = 1 M = 10 603-199-00-8 etoxazol (ISO); (RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole — 153233-91-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 … 1,045 unchanged lines … H410 GHS09 Wng H362 H410 M = 100 M = 1000 605-001-00-5 formaldehyde …% 200-001-8 50-00-0 Carc. 1B M = 1000 604-092-00-9 phenol, dodecyl-, branched [1]; phenol, 2-dodecyl-, branched; phenol, 3-dodecyl-, branched; phenol, 4-dodecyl-, branched; phenol, (tetrapropenyl) derivatives [2] 310-154-3 [1] 121158-58-5 [1] 74499-35-7 [2] Skin Corr. 1C Aquatic Acute 1 Aquatic Chronic 1 H314 H400 H410 GHS05 GHS09 Dgr H314 H410 M = 10 M = 10 605-001-00-5 formaldehyde …% 200-001-8 50-00-0 Carc. 1B Muta. 2 Acute Tox. 3* Acute Tox. 3* … 755 unchanged lines … (RS)-5-methylamino-2-phenyl-4-(α,α,α-trifluoro-m-tolyl)furan-3(2H)-one — 96525-23-4 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 606-054-00-7 isoxaflutole (ISO); 5-cyclopropyl-1,2-oxazol-4-yl α,α,α-trifluoro-2-mesyl-p-tolyl ketone — 141112-29-0 Repr. 2 Wng H410 606-054-00-7 isoxaflutole (ISO); 5-cyclopropyl-1,2-oxazol-4-yl α,α,α-trifluoro-2-mesyl-p-tolyl ketone — 141112-29-0 Repr. 2 Aquatic Acute 1 Aquatic Chronic 1 H361d *** Aquatic Chronic 1 H361d*** H400 H410 GHS08 GHS09 Wng H361d *** H410 606-055-00-2 1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone 411-180-9 92836-10-7 Acute Tox. 4 * Wng H361d*** H410 M = 10 M = 100 606-055-00-2 1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone 411-180-9 92836-10-7 Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 H302 H373 ** … 473 unchanged lines … Wng H351 H302 H411 606-147-00-2 cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one 405-230-9 101205-02-1 Repr. 2 H361d GHS08 Wng H361d 607-001-00-0 formic acid ... % 200-579-1 64-18-6 Skin Corr. 1A H314 GHS05 Wng H361d 606-148-00-8 carvone (ISO); 2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one; [1] d-carvone; (5S)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one; [2] l-carvone; (5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one [3] 202-759-5 [1] 218-827-2 [2] 229-352-5 [3] 99-49-0 [1] 2244-16-8 [2] 6485-40-1 [3] Skin Sens. 1 H317 GHS07 Wng H317 606-149-00-3 tembotrione (ISO); 2-{2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl}cyclohexane-1,3-dione — 335104-84-2 Repr. 2 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361d H373 (eyes, kidneys, liver) H317 H400 H410 GHS08 GHS07 GHS09 Wng H361d H373 (eyes, kidneys, liver) H317 H410 M = 100 M = 10 607-001-00-0 formic acid ... % 200-579-1 64-18-6 Skin Corr. 1A H314 GHS05 Dgr H314 Skin Corr. 1A; H314: C ≥ 90 % Skin Corr. 1B; H314: 10 % ≤ C < 90 % Skin Irrit. 2; H315: 2 % ≤ C < 10 % … 1,789 unchanged lines … Dgr H318 607-194-00-1 propylene carbonate 203-572-1 108-32-7 Eye Irrit. 2 H319 GHS07 Wng H319 607-195-00-7 2-methoxy-1-methylethyl acetate 203-603-9 108-65-6 Flam. Liq. 3 H226 GHS02 Wng H226 607-196-00-2 heptanoic acid 203-838-7 111-14-8 Skin Corr. 1B H314 GHS05 Dgr H314 607-197-00-8 nonanoic acid 203-931-2 112-05-0 Skin Corr. 1B H314 GHS05 Dgr H314 607-198-00-3 propyl 3,4,5-trihydroxybenzoate 204-498-2 121-79-9 Acute Tox. 4 * Dgr H314 607-197-00-8 nonanoic acid 203-931-2 112-05-0 Skin Irrit. 2 Eye Irrit. 2 Aquatic Chronic 3 H315 H319 H412 GHS07 Wng H315 H319 H412 607-198-00-3 propyl 3,4,5-trihydroxybenzoate 204-498-2 121-79-9 Acute Tox. 4 * Skin Sens. 1 H302 H317 GHS07 Wng H302 … 2,824 unchanged lines … GHS09 Wng H302 H336 H411 608-001-00-3 acetonitrile; H411 607-707-00-9 fenoxaprop-P-ethyl (ISO); ethyl (2R)-2-{4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy}propanoate — 71283-80-2 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H373 (kidneys) H317 H400 H410 GHS08 GHS07 GHS09 Wng H373 (kidneys) H317 H410 M = 1 M = 1 607-708-00-4 octanoic acid 204-677-5 124-07-2 Skin Corr. 1C Aquatic Chronic 3 H314 H412 GHS05 Dgr H314 H412 607-709-00-X decanoic acid 206-376-4 334-48-5 Skin Irrit. 2 Eye Irrit. 2 Aquatic Chronic 3 H315 H319 H412 GHS07 Wng H315 H319 H412 607-710-00-5 1,2-benzenedicarboxylic acid, dihexyl ester, branched and linear 271-093-5 68515-50-4 Repr. 1B H360FD GHS08 Dgr H360FD 607-711-00-0 spirotetramat (ISO); (5s,8s)-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-yl ethyl carbonate — 203313-25-1 Repr. 2 STOT SE 3 Eye Irrit. 2 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 H361fd H335 H319 H317 H400 H410 GHS08 GHS07 GHS09 Wng H361fd H335 H319 H317 H410 M = 1 M = 1 607-712-00-6 dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate 250-778-2 31717-87-0 Repr. 2 STOT RE 2 Skin Corr. 1C Skin Sens. 1A Aquatic Chronic 1 H361d H373 (liver) H314 H317 H410 GHS08 GHS05 GHS07 GHS09 Dgr H361d H373 (liver) H314 H317 H410 EUH071 M = 1 607-713-00-1 fenpyroximate (ISO); tert-butyl 4-[({(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino}oxy)methyl]benzoate — 134098-61-6 Acute Tox. 3 Acute Tox. 2 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 H301 H330 H317 H400 H410 GHS06 GHS09 Dgr H301 H330 H317 H410 M = 100 M = 1000 607-714-00-7 triflusulfuron-methyl; methyl 2-({[4-(dimethylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]carbamoyl}sulfamoyl)-3-methylbenzoate — 126535-15-7 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H400 H410 GHS08 GHS09 Wng H351 H410 M = 100 M = 10 607-715-00-2 bifenazate (ISO); isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazinecarboxylate 442-820-5 149877-41-8 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H373 H317 H400 H410 GHS08 GHS07 GHS09 Wng H373 H317 H410 M = 1 M = 1 608-001-00-3 acetonitrile; cyanomethane 200-835-2 75-05-8 Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * … 6,457 unchanged lines … H315 GHS08 Wng H351 H319 H315 EUH014 613-042-00-5 imazalil (ISO); 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 252-615-0 35554-44-0 Acute Tox. 4 * Acute Tox. 4 * H315 EUH014 613-042-00-5 imazalil (ISO); 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 252-615-0 35554-44-0 Carc. 2 Acute Tox. 3 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H332 H302 Aquatic Chronic 1 H351 H301 H332 H318 H400 H410 GHS05 GHS07 H410 GHS08 GHS06 GHS05 GHS09 Dgr H332 H302 Dgr H351 H301 H332 H318 H410 613-043-00-0 imazalil sulphate (ISO) powder; H410 M = 10 613-043-00-0 imazalil sulphate (ISO) powder; 1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1] (±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] 261-351-5 [1] 281-291-3 [2] 58594-72-2 [1] … 182 unchanged lines … H400 H410 GHS09 Wng H302 H410 613-057-00-7 dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine 216-474-9 1593-77-7 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 H319 H335 H315 H411 GHS07 H410 613-057-00-7 dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine 216-474-9 1593-77-7 Repr. 2 STOT RE 2 Skin Corr. 1C Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 H361d H373 (liver) H314 H317 H400 H410 GHS08 GHS05 GHS07 GHS09 Wng H319 H335 H315 H411 613-058-00-2 permethrin (ISO); Dgr H361d H373 (liver) H314 H317 H410 EUH071 M = 1 M = 1 613-058-00-2 permethrin (ISO); m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 258-067-9 52645-53-1 Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 … 682 unchanged lines … GHS09 Wng H302 H319 H410 613-133-00-X etridiazole (ISO); 5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole 219-991-8 2593-15-9 Carc. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * H410 613-133-00-X etridiazole (ISO); 5-ethoxy-3-trichloromethyl- 1,2,4-thiadiazole 219-991-8 2593-15-9 Carc. 2 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H331 H312 H302 H317 H400 H410 GHS06 GHS08 H410 GHS08 GHS07 GHS09 Dgr H351 H331 H312 Wng H351 H302 H410 613-134-00-5 myclobutanil(ISO); H317 H410 M = 1 M = 1 613-134-00-5 myclobutanil(ISO); 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile — 88671-89-0 Repr. 2 Acute Tox. 4 * Eye Irrit. 2 … 71 unchanged lines … Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 613-149-00-7 pyridaben (ISO); 2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one 405-700-3 96489-71-3 Acute Tox. 3 * Acute Tox. 3 * H412 613-149-00-7 pyridaben (ISO); 2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one 405-700-3 96489-71-3 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H331 H301 H400 H410 GHS06 GHS09 Dgr H331 H301 H410 613-150-00-2 2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1—b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione 406-295-6 — Aquatic Chronic 4 H413 — H413 613-151-00-8 1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine 406-360-9 104218-44-2 Aquatic Chronic 4 H413 — H413 613-152-00-3 phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate 406-600-2 89392-03-0 Skin Sens. 1 H410 M = 1000 M = 1000 613-150-00-2 2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1—b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione 406-295-6 — Aquatic Chronic 4 H413 — H413 613-151-00-8 1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine 406-360-9 104218-44-2 Aquatic Chronic 4 H413 — H413 613-152-00-3 phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate 406-600-2 89392-03-0 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 … 1,171 unchanged lines … Wng H361d H302 H410 M = 1 M = 1 613-318-00-5 fenpyrazamine (ISO); S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydro-1H-pyrazole-1-carbothioate - 473798-59-3 Aquatic Chronic 2 H411 GHS09 H411 614-001-00-4 nicotine (ISO); M = 1 613-318-00-5 fenpyrazamine (ISO); S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydro-1H-pyrazole-1-carbothioate - 473798-59-3 Aquatic Chronic 2 H411 GHS09 H411 613-319-00-0 imidazole 206-019-2 288-32-4 Repr. 1B Acute Tox. 4 Skin Corr. 1C H360D H302 H314 GHS08 GHS07 GHS05 Dgr H360D H302 H314 613-320-00-6 lenacil (ISO); 3-cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione 218-499-0 2164-08-1 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H400 H410 GHS08 GHS09 Wng H351 H410 M = 10 M = 10 614-001-00-4 nicotine (ISO); 3-(N-methyl-2-pyrrolidinyl)pyridine 200-193-3 54-11-5 Acute Tox. 1 Acute Tox. 3 * Aquatic Chronic 2 H310 … 1,718 unchanged lines … H318 H317 H410 M = 10 M = 1 616-213-00-2 mandipropamid (ISO); 2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide — 374726-62-2 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 1 M = 1 616-214-00-8 metosulam (ISO); N-(2,6-dichloro-3-methylphenyl)-5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide — 139528-85-1 Carc. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H373 (eyes, kidneys) H400 H410 GHS08 GHS09 Wng H351 H373 (eyes, kidneys) H410 M = 1000 M = 100 616-215-00-3 dimethenamid-P (ISO); 2-chloro-N-(2,4-dimethyl-3-thienyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide — 163515-14-8 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 M = 10 M = 10 616-216-00-9 flonicamid (ISO); N-(cyanomethyl)-4-(trifluoromethyl)pyridine-3-carboxamide — 158062-67-0 Acute Tox. 4 H302 GHS07 Wng H302 616-217-00-4 sulfoxaflor (ISO); [methyl(oxo){1-[6-(trifluoromethyl)-3-pyridyl]ethyl}-λ6-sulfanylidene]cyanamide — 946578-00-3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 M = 1 M = 1 617-001-00-2 di-tert-butyl peroxide 203-733-6 110-05-4 Org. Perox. E Flam. Liq. 2 Muta. 2 H242 … 1,204 unchanged lines … Dgr H350 H340 H J 648-154-00-3 Fuels, jet aircraft, coal solvent extn., hydrocracked hydrogenated; [Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 225 oC (356 oF to 473 oF). Composed primarilyof hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.] 302-694-3 94114-58-6 Carc. 2 H351 GHS08 [Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 225 oC (356 oF to 473 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.] 302-694-3 94114-58-6 Carc. 2 H351 GHS08 Wng H350 H 648-155-00-9 Fuels, diesel, coal solvent extn., hydrocracked hydrogenated; [Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200 oC to 280 oC (392 oF to 536 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C11 through C14.] 302-695-9 94114-59-7 Carc. 2 H351 GHS08 … 187 unchanged lines … Dgr H350 H 649-049-00-5 Petroleum; Crude oil; [A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for theirrecovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.] 232-298-5 8002-05-9 Carc. 1B H350 GHS08 [A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for theirrecoveryor conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.] 232-298-5 8002-05-9 Carc. 1B H350 GHS08 Dgr H350 H 649-050-00-0 Distillates (petroleum), light paraffinic; Unrefined or mildly refined baseoil; … 652 unchanged lines … H340 K U 649-109-00-0 Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber; petroleum gas; [A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil.It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-175-6 68952-81-8 Press. Gas [A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-175-6 68952-81-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 … 391 unchanged lines … H340 K U 649-140-00-X Tail gas (petroleum), catalytic cracker refractionation absorber; Refinery gas; [A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. Itconsists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 270-805-1 68478-25-1 Press. Gas [A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 270-805-1 68478-25-1 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 … 357 unchanged lines … H340 K U 649-168-00-2 Gases (petroleum), crude distn. and catalytic cracking; Refinery gas; [A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen,carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-563-5 68989-88-8 Press. Gas [A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-563-5 68989-88-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 … 3,718 unchanged lines … 007-003-00-6 chlormequat chloride (ISO); 2-chloroethyltrimethylammonium chloride 213-666-4 999-81-5 Xn; R21/22 Xn R: 21/22 S: (2-)36/37 007-004-00-1 nitric acid ... % 231-714-2 7697-37-2 O; R8 S: (2-)36/37 007-004-00-1 nitric acid … % 231-714-2 7697-37-2 O; R8 C; R35 O; C R: 8-35 S: (1/2-)23-26-36-45 C; R35: C ≥ 20 % C; R34: 5 % ≤ C < 20 % Footnote: O; R8: C ≥ 70 % B S: (1/2-)26-28- 36/37/39-45-63 O; R8: C ≥ 65 % C; R35: C ≥ 20 % C; R34: 5 % ≤ C < 20 % B 007-006-00-2 ethyl nitrite 203-722-6 109-95-5 E; R2 Xn; R20/21/22 E; Xn R: 2-20/21/22 … 437 unchanged lines … R16 R52-53 F R: 11-16-52/53 S: (2-)7-43-61 015-003-00-2 calcium phosphide; tricalcium diphosphide 215-142-0 1305-99-3 F; R15 T+; R28 R29 S: (2-)7-43-61 015-003-00-2 calcium phosphide; tricalcium diphosphide 215-142-0 1305-99-3 F; R15/29 T+; R26/28 Xn; R21 R32 Xi; R38-41 N; R50 F; T+; N R: 15/29-28-50 S: (1/2-)22-28-36/37-43-45-61 N; R50: C ≥ 0,25 % 015-004-00-8 aluminium phosphide 244-088-0 20859-73-8 F; R15/29 R: 15/29-21-26/28-32-38-41-50 S:(1/2-)26-28-30-36/37/39-43-45-60-61 N; R50: C ≥ 0,25 % 015-004-00-8 aluminium phosphide 244-088-0 20859-73-8 F; R15/29 T+; R26/28 Xn; R21 R32 … 1,379 unchanged lines … R: 22-35 S: (1/2-)26-36/37/39-45 C; R35: C ≥ 5 % C; R34: 2 % ≤ C < 5 % Xi; R36/38: 0.5 % ≤ C < 2 % 020-001-00-X calcium 231-179-5 7440-70-2 F; R15 F Xi; R36/38: 0.5 % ≤ C < 2 % 019-003-00-3 potassium (E,E)-hexa-2,4-dienoate 246-376-1 24634-61-5 Xi; R36 Xi R: 36 S: (2-)25-46 020-001-00-X calcium 231-179-5 7440-70-2 F; R15 F R: 15 S: (2-)8-24/25-43 020-002-00-5 calcium cyanide 209-740-0 592-01-8 T+; R28 R32 … 1,172 unchanged lines … R: 50/53 S: 60-61 030-015-00-8 tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate 440-060-9 - N; R51-53 N R: 51/53 S: 61 031-001-00-4 gallium arsenide 215-114-8 1303-00-0 Carc. Cat. 2; R45 S: 61 031-001-00-4 gallium arsenide 215-114-8 1303-00-0 Repr. Cat. 2; R60 Carc. Cat. 2; R45 T; R48/23 T R: 45-48/23 R: 45-48/23-60 S: 45-53 E 033-001-00-X arsenic 231-148-6 7440-38-2 T; R23/25 N; R50-53 T; N … 256 unchanged lines … R: 23/24/25-50/53 S: (1/2-)26-27-28-45-60-61 T; R23/24/25: C ≥ 0,5 % Xn; R20/21/22: 0,1 % ≤ C < 0,5 % A1 050-008-00-3 tributyltin compounds, with the exception of those specified elsewhere in this Annex — — T; R25-48/23/25 050-008-00-3 tributyltin compounds, with the exception of those specified elsewhere in this annex — — Repr. Cat. 2; R60-61 T; R25-48/23/25 Xn; R21 Xi; R36/38 N; R50-53 T; N R: 21-25-36/38-48/23/25-50/53 S: (1/2-)36/37/39-45-60-61 T; R25: C ≥ 2,5 % R: 21-25-36/38-48/23/25-50/53-60-61 S: 45-53-60-61 T; R25: C ≥ 2,5 % Xn; R22: 0,25 % ≤ C < 2,5 % Xn: R21: C ≥ 1 % T; R48/23/25: C ≥ 1 % Xn; R48/20/22: 0,25 % ≤ C < 1 % Xi; R36/38: C ≥ 1 % N; R50-53: C ≥ 2,5 % N; R51-53: 0,25 % ≤ C < 2,5 % R52-53: 0,025 % ≤ C < 0,25 % A1 R52-53: 0,025 % ≤ C < 0,25 % A 1 050-009-00-9 fluorotripentylstannane; [1] hexapentyldistannoxane [2] 243-546-7 [1] 247-143-7 [2] 20153-49-5 [1] … 1,984 unchanged lines … S: (2-)25-26 603-102-00-9 1,2-epoxybutane 203-438-2 106-88-7 F; R11 Carc. Cat. 3; R40 Xn; R20/21/22 Xi; R36/37/38 R52-53 F; Xn R: 11-20/21/22-36/37/38-40-52/53 S: (2-)9-16-29-36/37-61 603-103-00-4 oxirane, mono[(C12-14-alkyloxy)methyl] derivs. 271-846-8 68609-97-2 Xi; R38 Xi; R36/37/38 F; Xn R: 11-20/21/22-36/37/38-40- S: (2-)9-16-29-36/37-46 603-103-00-4 oxirane, mono[(C12-14-alkyloxy)methyl] derivs. 271-846-8 68609-97-2 Xi; R38 R43 Xi R: 38-43 S: (2-)24-37 603-104-00-X fenarimol (ISO); … 335 unchanged lines … S: 61 603-196-00-1 2-(7-ethyl-1H-indol-3-yl)ethanol 431-020-1 41340-36-7 Xn; 22-48/22 N; R51-53 Xn; N R: 22-48/22-51/53 S: (2-)36/37/39-61 603-197-00-7 tebuconazole (ISO); 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol 403-640-2 107534-96-3 Repr. Cat. 3; R63 S: (2-)36/37/39-61 603-197-00-7 tebuconazole (ISO); 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol 403-640-2 107534-96-3 Repr. Cat. 3; R63 Xn; R22 N; R51-53 Xn; N R: 22-51/53-63 S: (2-)22-36/37-61 603-199-00-8 etoxazol (ISO); N; R50-53 Xn; N R: 22-50/53-63 S: (2-)22-36/37-60-61 N; R50-53: C ≥ 25 % N; R51-53: 2,5 % ≤ C <25 % R52-53: 0,25 % ≤ C < 2,5 % 603-199-00-8 etoxazol (ISO); (RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole — 153233-91-1 N; R50-53 N R: 50/53 S: 60-61 N; R50-53: C ≥ 0,25 % … 538 unchanged lines … R: 50/53-64 S: 60-61 N; R50-53: C ≥ 0,25 % N; R51-53: 0,025 % ≤ C < 0,25 % R52-53: 0,0025 % ≤ C < 0,025 % 605-001-00-5 formaldehyde …% 200-001-8 50-00-0 Carc. Cat. 2; R45 R52-53: 0,0025 % ≤ C < 0,025 % 604-092-00-9 phenol, dodecyl-, branched [1]; phenol, 2-dodecyl-, branched; phenol, 3-dodecyl-, branched; phenol, 4-dodecyl-, branched; phenol, (tetrapropenyl) derivatives [2] 310-154-3 [1]-[2] 121158-58-5 [1] 74499-35-7 [2] C; R34 N; R50-53 C; N R: 34-50/53 S: (1/2-)26-36/37/39-45-61 N; R50-53: C ≥ 2,5 % N; R51-53: 0,25 % ≤ C < 2,5 % R52-53: 0,025 % ≤ C < 0,25 % 605-001-00-5 formaldehyde …% 200-001-8 50-00-0 Carc. Cat. 2; R45 Muta. Cat. 3; R68 T; R23/24/25 C; R34 … 378 unchanged lines … S: 61 606-053-00-1 flurtamone (ISO); (RS)-5-methylamino-2-phenyl-4-(α, α,α-trifluoro-m-tolyl)furan-3(2H)-one — 96525-23-4 N; R50-53 N R: 50/53 S: 60-61 606-054-00-7 isoxaflutole (ISO); 5-cyclopropyl-1,2-oxazol-4-yl α, α,α-trifluoro-2-mesyl-p-tolyl ketone — 141112-29-0 Repr. Cat. 3; R63 S: 60-61 606-054-00-7 isoxaflutole (ISO); 5-cyclopropyl-1,2-oxazol-4-yl α, α,α-trifluoro-2-mesyl-p-tolyl ketone — 141112-29-0 Repr. Cat. 3; R63 N; R50-53 Xn; N R: 50/53-63 S: (2-)36/37-60-61 606-055-00-2 1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone 411-180-9 92836-10-7 Xn; R22-48/22 S: (2-)36/37-60-61 N; R50-53: C ≥ 2,5 % N; R51-53: 0,25 % ≤ C < 2,5 % R52-53: 0,025 % ≤ C < 0,25 % 606-055-00-2 1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone 411-180-9 92836-10-7 Xn; R22-48/22 N; R51-53 Xn; N R: 22-48/22-51/53 S: (2-)24-36-61 606-056-00-8 4-chloro-3',4'-dimethoxybenzophenone 404-610-1 116412-83-0 N; R50-53 N … 287 unchanged lines … S: (2-)36/37-60-61 606-147-00-2 cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one 405-230-9 101205-02-1 F; R11 Repr. Cat. 3; R63 F; Xn R: 11-63 S: (2-)16-36/37-46 607-001-00-0 formic acid … % 200-579-1 64-18-6 C; R35 C S: (2-)16-36/37-46 606-148-00-8 carvone (ISO); 2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one; [1] d-carvone; (5S)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one; [2] l-carvone; (5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one [3] 202-759-5 [1] 218-827-2 [2] 229-352-5 [3] 99-49-0 [1] 2244-16-8 [2] 6485-40-1 [3] R43 Xi R: 43 S: (2-)24-37 606-149-00-3 tembotrione (ISO); 2-{2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl}cyclohexane-1,3-dione 335104-84-2 Repr. Cat. 3; R63 Xn; R48/22 R43 N; R50-53 Xn; N R: 43-48/22-50/53-63 S: (2-)36/37-46-60-61 N; R50-53: C ≥ 0,25 % N; R51-53: 0,025 % ≤ C < 0,25 % R52-53: 0,0025 % ≤ C < 0,025 % 607-001-00-0 formic acid … % 200-579-1 64-18-6 C; R35 C R: 35 S: (1/2-)23-26-45 C; R35: C ≥ 90 % C; R34: 10 % ≤ C < 90 % … 925 unchanged lines … S: (2-) 607-195-00-7 2-methoxy-1-methylethyl acetate 203-603-9 108-65-6 R10 R: 10 S: (2-) 607-196-00-2 heptanoic acid 203-838-7 111-14-8 C; R34 C R: 34 S: (1/2-)26-28-36/37/39-45 607-197-00-8 nonanoic acid 203-931-2 112-05-0 C; R34 C R: 34 S: (1/2-)26-28-36/37/39-45 607-198-00-3 propyl 3,4,5-trihydroxybenzoate 204-498-2 121-79-9 Xn; R22 S: (1/2-)26-28-36/37/39-45 607-197-00-8 nonanoic acid 203-931-2 112-05-0 Xi; R36/38 N; R51-53 Xi; N R: 36/38-51/53 S: (2-)46-61 607-198-00-3 propyl 3,4,5-trihydroxybenzoate 204-498-2 121-79-9 Xn; R22 R43 Xn R: 22-43 S: (2-)24-37 607-199-00-9 octyl 3,4,5-trihydroxybenzoate 213-853-0 1034-01-1 Xn; R22 … 1,694 unchanged lines … S: (1/2-)26-39-45-63 607-706-00-3 methyl 2,5-dichlorobenzoate 220-815-7 2905-69-3 Xn; R22 N; R51-53 Xn; N R: 22-51/53 S: (2-) 46-61 608-001-00-3 acetonitrile; S: (2-) 46-61 607-707-00-9 fenoxaprop-P-ethyl (ISO); ethyl (2R)-2-{4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy}propanoate — 71283-80-2 Xn; R48/22 R43 N; R50-53 Xn; N R: 43-48/22-50/53 S: (2-)24-37-46-60-61 N; R50-53: C ≥ 25 % N; R51-53: 2,5 % ≤ C < 25 % R52-53: 0,25 % ≤ C < 2,5 % 607-708-00-4 octanoic acid 204-677-5 124-07-2 C; R34 N; R51-53 C; N R: 34-51/53 S: (1/2-)26-36/37/39-45-61 607-709-00-X decanoic acid 206-376-4 334-48-5 Xi; R36/38 N; R51-53 Xi; N R: 36/38-51/53 S: (2-)25-46-61 607-710-00-5 1,2-Benzenedicarboxylic acid, dihexyl ester, branched and linear 271-093-5 68515-50-4 Repr. Cat. 2; R60-61 T R: 60-61 S: 53-45 607-711-00-0 spirotetramat (ISO); (5s,8s)-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-yl ethyl carbonate — 203313-25-1 Repr. Cat. 3; R62-63 Xi; R36/37 R43 N; R50-53 Xn; N R: 36/37-43-50/53-62-63 S: (2-)36/37-60-61 Xi; R43: C ≥ 0,1 % N; R50-53: C ≥ 25 % N; R51-53: 2,5 % ≤ C < 25 % R52-53: 0,25 % ≤ C < 2,5 % 607-712-00-6 dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate 250-778-2 31717-87-0 Repr. Cat. 3; R63 C; R34 R43 N; R51-53 C; N R: 34-43-51/53-63 S: (1/2-)26-28-36/37/39-45-61 C; R34: C ≥ 10 % Xi: R36/37/38: 5 % ≤ C < 10 % 607-713-00-1 fenpyroximate (ISO); tert-butyl 4-[({(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino}oxy)methyl]benzoate — 134098-61-6 T+; R26 Xn; R22 R43 N; R50-53 T+; N R: 22-26-43-50/53 S: (1/2-)28-36/37-45-60-61-63 N; R50-53: C ≥ 0,25 % N; R51-53: 0,025 % ≤ C < 0,25 % R52-53: 0,0025 % ≤ C < 0,025 % 607-714-00-7 triflusulfuron-methyl; methyl 2-({[4-(dimethylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]carbamoyl}sulfamoyl)-3-methylbenzoate — 126535-15-7 Carc. Cat. 3; R40 N; R50-53 Xn; N R: 40-50/53 S: (2-)36/37-60-61 N; R50-53: C ≥ 0,25 % N; R51-53: 0,025 % ≤ C < 0,25 % R52-53: 0,0025 % ≤ C < 0,025 % 607-715-00-2 bifenazate (ISO); isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazinecarboxylate 442-820-5 149877-41-8 R43 N; R50-53 Xi; N R: 43-50/53 S: (2-)24-37-60-61 N; R50-53: C ≥ 25 % N; R51-53: 2,5 % ≤ C < 25 % R52-53: 0,25 % ≤ C < 2,5 % 608-001-00-3 acetonitrile; cyanomethane 200-835-2 75-05-8 F; R11 Xn; R20/21/22 Xi; R36 F; Xn … 2,979 unchanged lines … Carc. Cat. 3; R40 Xi; R36/38 Xn R: 14-36/38-40 S: (2-)26-30-36-38 613-042-00-5 imazalil (ISO); 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 252-615-0 35554-44-0 Xn; R20/22 S: (2-)26-30-36-38 613-042-00-5 imazalil (ISO); 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 252-615-0 35554-44-0 Carc. Cat. 3; R40 Xn; R20/22 Xi; R41 N; R50-53 Xn; N R: 20/22-41-50/53 S: (2-)26-39-60-61 613-043-00-0 imazalil sulphate (ISO) powder; N; R51-53 Xn; N R: 20/22-40-41-51/53 S: (2-)26-36/37/39-46-61 613-043-00-0 imazalil sulphate (ISO) powder; 1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1] (±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] 261-351-5 [1] 281-291-3 [2] 58594-72-2 [1] … 83 unchanged lines … difenzoquat methyl sulfate 256-152-5 43222-48-6 Xn; R22 N; R50-53 Xn; N R: 22-50/53 S: (2-)60-61 613-057-00-7 dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine 216-474-9 1593-77-7 Xi; R36/37/38 N; R51-53 Xi; N R: 36/37/38-51/53 S: (2-)26-61 613-058-00-2 permethrin (ISO); S: (2-)60-61 613-057-00-7 dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine 216-474-9 1593-77-7 Repr. Cat. 3; R63 C; R34 R43 N; R50-53 C; N R: 34-43-50/53-63 S: (1/2-)26-28-36/37/39-45-60-61 C; R34: C ≥ 10 % Xi; R36/37/38: 5 % ≤ C < 10 % N; R50-53: C ≥ 25 % N; R51-53: 2,5 % ≤ C < 25 % R52-53: 0,25 % ≤ C < 2,5 % 613-058-00-2 permethrin (ISO); m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 258-067-9 52645-53-1 Xn; R20/22 R43 N; R50-53 Xn; N … 313 unchanged lines … Xi; R36 N; R50-53 Xn; N R: 22-36-50/53 S: (2-)60-61 613-133-00-X etridiazole (ISO); 5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole 219-991-8 2593-15-9 Carc. Cat. 3; R40 T; R23 Xn; R21/22 N; R50-53 T; N R: 21/22-23-40-50/53 S: (1/2-)36/37-38-45-60-61 613-134-00-5 myclobutanil (ISO); S: (2-)60-61 613-133-00-X etridiazole (ISO); 5-ethoxy-3-trichloromethyl- 1,2,4-thiadiazole 219-991-8 2593-15-9 Carc. Cat. 3; R40 Xn; R22 R43 N; R50-53 Xn; N R: 22-40-43-50/53 S: (2-)36/37-46-60-61 N; R50-53: C ≥ 25 % N; R51-53: 2,5 % ≤ C < 25 % R52-53: 0,25 % ≤ C < 2,5 % 613-134-00-5 myclobutanil (ISO); 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile — 88671-89-0 Repr. Cat. 3; R63 Xn; R22 Xi; R36 … 44 unchanged lines … S: (2-)26-39 613-148-00-1 tetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane 411-240-4 143683-23-2 R43 R52-53 Xi R: 43-52/53 S: (2-)22-24/25-37-61 613-149-00-7 pyridaben (ISO); 2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one 405-700-3 96489-71-3 T; R23/25 S: (2-)22-24/25-37-61 613-149-00-7 pyridaben (ISO); 2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one 405-700-3 96489-71-3 T; R23/25 N; R50-53 T; N R: 23/25-50/53 S: (1/2-)36/37-45-60-61 613-150-00-2 2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1-b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione 406-295-6 — R53 R: 53 S: (1/2-)36/37-45-60-61 N; R50-53: C ≥ 0,025 % N; R51-53: 0,0025 % ≤ C < 0,025 % R52-53: 0,00025 % ≤ C < 0,0025 % 613-150-00-2 2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1-b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione 406-295-6 — R53 R: 53 S: 61 613-151-00-8 1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine 406-360-9 104218-44-2 R53 R: 53 S: 61 613-152-00-3 phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate 406-600-2 89392-03-0 R43 N; R51-53 Xi; N … 603 unchanged lines … N; R51-53: 2,5 % ≤ C < 25 % R52-53: 0,25 % ≤ C < 2,5 % 613-318-00-5 fenpyrazamine (ISO); S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydro-1H-pyrazole-1-carbothioate — 473798-59-3 N; R51-53 N R: 51/53 S: 60-61 614-001-00-4 nicotine (ISO); S: 60-61 613-319-00-0 imidazole 206-019-2 288-32-4 Repr. Cat 2; R61 Xn; R22 C; R34 T; C R: 22-34-61 S: 53-45 613-320-00-6 lenacil (ISO); 3-cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione 218-499-0 2164-08-1 Carc. Cat. 3; R40 N; R50-53 Xn; N R: 40-50/53 S: (2-)36/37-60-61 N; R50-53: C ≥ 2,5 % N; R51-53: 0,25 % ≤ C < 2,5 % R52-53: 0,025 % ≤ C < 0,25 % 614-001-00-4 nicotine (ISO); 3-(N-methyl-2-pyrrolidinyl)pyridine 200-193-3 54-11-5 T+; R27 T; R25 N; R51-53 T+; N … 959 unchanged lines … R43 N; R50 T; N R: 22-23-41-43-48/23-50 S: (1/2-)24-26-37/39-45-63 N; R50: C ≥ 2,5 % 617-001-00-2 di-tert-butyl peroxide 203-733-6 110-05-4 O; R7 S: (1/2-)24-26-37/39-45-63 N; R50: C ≥ 2,5 % 616-213-00-2 mandipropamid (ISO); 2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide — 374726-62-2 N; R50-53 N R: 50/53 S: 60-61 N; R50-53: C ≥ 25 % N; R51-53: 2,5 % ≤ C <25 % R52-53: 0,25 % ≤ C < 2,5 % 616-214-00-8 metosulam (ISO); N-(2,6-dichloro-3-methylphenyl)-5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide — 139528-85-1 Carc. Cat. 3; R40 Xn; R48/22 N; R50-53 Xn; N R: 40-48/22-50/53 S: (2-)36/37-46-60-61 N; R50-53: C ≥ 0,025 % N; R51-53: 0,0025 % ≤ C < 0,025 % R52/53: 0,00025 % ≤ C < 0,0025 % 616-215-00-3 dimethenamid-P (ISO); 2-chloro-N-(2,4-dimethyl-3-thienyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide — 163515-14-8 Xn; R22 R43 N; R50-53 Xn; N R: 22-43-50/53 S: (2-)24-37-60-61 N; R50-53: C ≥ 2,5 % N; R51-53: 0,25 % ≤ C < 2,5 % R52-53: 0,025 % ≤ C < 0,25 % 616-216-00-9 flonicamid (ISO); N-(cyanomethyl)-4-(trifluoromethyl)pyridine-3-carboxamide — 158062-67-0 Xn; R22 Xn R: 22 S: (2-)46 616-217-00-4 sulfoxaflor (ISO); [methyl(oxo){1-[6-(trifluoromethyl)-3-pyridyl]ethyl}-λ6-sulfanylidene]cyanamide — 946578-00-3 Xn; R22 N; R50-53 Xn; N R: 22-50/53 S: (2-)60-61 N; R50-53: C ≥ 25 % N; R51-53: 2,5 % ≤ C < 25 % R52-53: 0,25 % ≤ C < 2,5 % 617-001-00-2 di-tert-butyl peroxide 203-733-6 110-05-4 O; R7 F; R11 Muta. Cat. 3, R68 O; F; Xn R: 7-11-68 … 4,369 unchanged lines … S: 61 650-055-00-5 silver sodium zirconium hydrogenphosphate 422-570-3 155925-27-2 N; R50-53 N R: 50/53 S: 60-61

No text on either side: this unit was named by a signal that carries no text, and only the structural diff carries any.